If the world fails to protect the economy, COVID-19 will damage health not just now but also in the future
|
|
April 2020 |
Global trends in emerging infectious diseases
|
|
February 2008 |
COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don't
|
|
January 2020 |
Evolution and Emergence of Pathogenic Viruses: Past, Present, and Future
|
|
January 2017 |
Urbanization and Disease Emergence: Dynamics at the Wildlife–Livestock–Human Interface
|
|
January 2017 |
Risk factors for human disease emergence
|
|
July 2001 |
Emerging Infectious Diseases of Wildlife-- Threats to Biodiversity and Human Health
|
|
January 2000 |
Livestock infectious diseases and zoonoses
|
|
September 2009 |
Climate change and emerging infectious diseases
|
|
July 2001 |
Climate Change and Respiratory Infections
|
|
August 2016 |
The ecology of Anopheles mosquitoes under climate change: case studies from the effects of deforestation in East African highlands: Ecology of anopheles under climate change
|
|
February 2012 |
Why is tick-borne encephalitis increasing? A review of the key factors causing the increasing incidence of human TBE in Sweden
|
|
August 2012 |
What Makes Ticks Tick? Climate Change, Ticks, and Tick‐Borne Diseases
|
|
January 2008 |
Clinical features and laboratory diagnosis of emerging arthropod-transmitted viruses
|
|
November 2020 |
Seasonality and the dynamics of infectious diseases
|
|
March 2006 |
Approved Antiviral Drugs over the Past 50 Years
|
|
June 2016 |
Antiviral therapy: old and current issues
|
|
August 2012 |
Systems biology and combination therapy in the quest for clinical efficacy
|
|
August 2006 |
Synergistic antiviral effects against SARS-CoV-2 by plant-based molecules
|
|
June 2020 |
Systematic identification of synergistic drug pairs targeting HIV
|
|
October 2012 |
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
|
|
March 2020 |
Antiviral Natural Products and Herbal Medicines
|
|
January 2014 |
The influence of natural products upon drug discovery (Antiquity to late 1999)
|
|
January 2000 |
Marine cyanobacteria—a prolific source of natural products
|
|
November 2001 |
Bioproducts from Seaweeds: A Review with Special Focus on the Iberian Peninsula
|
|
May 2014 |
Microalgae for Biofuels and Animal Feeds
|
|
November 2013 |
Carrageenan nasal spray in virus confirmed common cold: individual patient data analysis of two randomized controlled trials
|
|
January 2014 |
Efficacy of a Carrageenan nasal spray in patients with common cold: a randomized controlled trial
|
|
January 2013 |
Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold
|
|
August 2010 |
The Intranasal Application of Zanamivir and Carrageenan Is Synergistically Active against Influenza A Virus in the Murine Model
|
|
June 2015 |
Inhibition of Influenza A Virus Infection by Fucoidan Targeting Viral Neuraminidase and Cellular EGFR Pathway
|
|
January 2017 |
Oral Fucoidan Attenuates Lung Pathology and Clinical Signs in a Severe Influenza A Mouse Model
|
|
May 2020 |
The effectiveness of Carraguard, a vaginal microbicide, in protecting women against high-risk human papillomavirus infection
|
|
January 2011 |
Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial
|
|
December 2008 |
An intravaginal ring that releases three antiviral agents and a contraceptive blocks SHIV-RT infection, reduces HSV-2 shedding, and suppresses hormonal cycling in rhesus macaques
|
|
June 2017 |
Algal Lectins as Potential HIV Microbicide Candidates
|
|
July 2012 |
In vitro and in vivo anti-herpes simplex virus activity of monogalactosyl diacylglyceride from Coccomyxa sp. KJ (IPOD FERM BP-22254), a green microalga
|
|
July 2019 |
Therapeutic efficacy in BALB/C mice of extract from marine alga Canistrocarpus cervicornis (Phaeophyceae) against herpes simplex virus type 1
|
|
May 2016 |
Antiviral Activity of the Marine Alga Symphyocladia latiuscula against Herpes Simplex Virus (HSV-1) in Vitro and Its Therapeutic Efficacy against HSV-1 Infection in Mice
|
|
January 2005 |
The inhibitory effects and mechanisms of polymannuroguluronate sulfate against human papillomavirus infection in vitro and in vivo
|
|
August 2020 |
Carrageenans: Biological properties, chemical modifications and structural analysis – A review
|
|
June 2009 |
Crossing barriers: infections of the lung and the gut
|
|
December 2008 |
Inactivation of Enveloped Viruses in Human Bodily Fluids by Purified Lipids
|
|
May 1994 |
Diterpenes from the Marine Algae of the Genus Dictyota
|
|
May 2018 |
Comparative study on the antiviral activity of selected monoterpenes derived from essential oils: ANTIVIRAL ACTIVITY OF MONOTERPENES DERIVED FROM ESSENTIAL OILS
|
|
August 2009 |
The eye as the discrete but defensible portal of coronavirus infection
|
|
January 2021 |
Mask use during COVID-19: A risk adjusted strategy
|
|
November 2020 |
Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19
|
|
December 2020 |
Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication
|
|
November 2017 |
Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism
|
|
December 2017 |
Multiple Antiviral Activities in Extracts of Seaweeds from British Columbia
|
|
January 1999 |
Drug Therapy in Dental Practice: General Principles: Part 1—Pharmacokinetic Considerations
|
|
December 2006 |
Anesthesia for the 21st Century
|
|
January 2000 |
Drug Delivery Systems: Entering the Mainstream
|
|
March 2004 |
Antiviral activity of 7-keto-stigmasterol obtained from green Antarctic algae Prasiola crispa against equine herpesvirus 1
|
|
September 2016 |
Anti-HIV / HCV Activity of Cyanobacterial Phycobiliproteins by a New Standardized Method Using Bacteriophage Surrogates
|
|
October 2019 |
Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development.
|
|
July 1997 |
Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin
|
|
September 2016 |
In vitro inhibitory effect of carrageenan oligosaccharide on influenza A H1N1 virus
|
|
November 2011 |
The Comparative Analysis of Antiviral Activity of Native and Modified Fucoidans from Brown Algae Fucus evanescens In Vitro and In Vivo
|
|
April 2020 |
Antiviral Activity against Avian Leucosis Virus Subgroup J of Degraded Polysaccharides from Ulva pertusa
|
|
August 2018 |
Additionally sulfated xylomannan sulfates from Scinaia hatei and their antiviral activities
|
|
October 2015 |
Immunomodulatory and Anti-IBDV Activities of the Polysaccharide AEX from Coccomyxa gloeobotrydiformis
|
|
February 2017 |
Loliolide in marine algae
|
|
March 2009 |
Virucidal and Synergistic Activity of Polyphenol-Rich Extracts of Seaweeds against Measles Virus
|
|
August 2018 |
In vitro Studies on The Inhibition of Replication of Zika and Chikungunya Viruses by Dolastane Isolated from Seaweed Canistrocarpus cervicornis
|
|
May 2020 |
In vitro bioavailability of chlorophyll pigments from edible seaweeds
|
|
February 2018 |
DAG tales: the multiple faces of diacylglycerol—stereochemistry, metabolism, and signaling
|
|
July 2015 |
Effects of triacylglycerol and diacylglycerol oils on blood clearance, tissue uptake, and hepatic apolipoprotein B secretion in mice
|
|
May 2007 |
Controversial role of plant sterol esters in the management of hypercholesterolaemia
|
|
September 2008 |
Phytosterols, Lipid Administration, and Liver Disease During Parenteral Nutrition
|
|
July 2015 |
Loliolide, a Carotenoid Metabolite, Is a Potential Endogenous Inducer of Herbivore Resistance
|
|
January 2019 |
New Loliolide Derivatives from the Brown Alga Undaria pinnatifida
|
|
January 2002 |
Loliolide - the most ubiquitous lactone
|
|
December 2015 |
The lectin–cell interaction and its implications to intestinal lectin-mediated drug delivery
|
|
March 2004 |
Investigation of lectin-modified insulin liposomes as carriers for oral administration
|
|
April 2005 |
Improving Efficacy, Oral Bioavailability, and Delivery of Paclitaxel Using Protein-Grafted Solid Lipid Nanoparticles
|
|
October 2016 |
In vitro antiviral activity of phlorotannins isolated from Ecklonia cava against porcine epidemic diarrhea coronavirus infection and hemagglutination
|
|
August 2013 |
Polyphenols: food sources and bioavailability
|
|
May 2004 |
Hepatoprotective Effect of C-Phycocyanin: Protection for Carbon Tetrachloride andR-(+)-Pulegone-Mediated Hepatotoxicty in Rats
|
|
August 1998 |
Effect of phycocyanin in zymosan-induced arthritis in mice?phycocyanin as an antiarthritic compound
|
|
October 1999 |
The Antiviral Activities and Mechanisms of Marine Polysaccharides: An Overview
|
|
December 2012 |
Herpes simplex virus type 1 variants arising after selection with an antiviral carrageenan: Lack of correlation between drug susceptibility and syn phenotype
|
|
July 2002 |
Antiviral Activity of a Carrageenan from Gigartina skottsbergii against Intraperitoneal Murine Herpes simplex Virus Infection
|
|
November 2006 |
Inhibitory Effects of Laminaria japonica Fucoidans Against Noroviruses
|
|
September 2020 |
Structural characterization and antiviral activity of two fucoidans from the brown algae Sargassum henslowianum
|
|
February 2020 |
Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro
|
|
July 2020 |
Sulphated Polysaccharides from Ulva clathrata and Cladosiphon okamuranus Seaweeds both Inhibit Viral Attachment/Entry and Cell-Cell Fusion, in NDV Infection
|
|
January 2015 |
Immune Activation of RAW264.7 Macrophages by Low Molecular Weight Fucoidan Extracted from New Zealand Undaria pinnatifida
|
|
September 2018 |
Neutrophils in viral infections: Current concepts and caveats
|
|
July 2015 |
Structural characteristics and in vitro macrophage activation of acetyl fucoidan from Cladosiphon okamuranus
|
|
February 2009 |
Stimulation of turbot phagocytes by Ulva rigida C. Agardh polysaccharides
|
|
April 2006 |
The immunomodulatory effect of LPS, laminaran and sulphated laminaran [beta(l,3)-D-glucan] on Atlantic salmon, Salmo salar L., macrophages in vitro
|
|
March 1995 |
Effects of κ-Carrageenan on the Non-Specific Defense System of Carp Cyprinus carpio
|
|
January 1997 |
Carrageenan Primes Leukocytes To Enhance Lipopolysaccharide-Induced Tumor Necrosis Factor Alpha Production
|
|
July 1999 |
Biocompatibility of Wound Management Products: A Study of the Effects of Various Polysaccharides on Murine L929 Fibroblast Proliferation and Macrophage Respiratory Burst
|
|
June 1993 |
Antiviral efficacy of orally delivered neoagarohexaose, a nonconventional TLR4 agonist, against norovirus infection in mice
|
|
December 2020 |
Activation of Murine Macrophages by Polysaccharide Fractions from Marine Algae ( Porphyra yezoensis )
|
|
January 1993 |
Macrophage Stimulation Activity of the Polysaccharide Fraction from a Marine Alga ( Porphyra yezoensis ): Structure-Function Relationships and Improved Solubility
|
|
January 1995 |
Fucoidan Isolated from Laminaria angustata var. longissima Induced Macrophage Activation
|
|
September 2010 |
Immunomodulating Activity of Arabinogalactan and Fucoidan In Vitro
|
|
December 2005 |
Synthesis and immunomodulatory activity of the sulfated tetrasaccharide motif of type B ulvanobiuronic acid 3-sulfate
|
|
January 2020 |
Immunomodulatory effect of dietary Saccharomyces cerevisiae, β-glucan and laminaran in mercuric chloride treated Nile tilapia (Oreochromis niloticus) and experimentally infected with Aeromonas hydrophila
|
|
May 2010 |
Carrageenans as Broad-Spectrum Microbicides: Current Status and Challenges
|
|
August 2020 |
Palmitic Acid Is a Novel CD4 Fusion Inhibitor That Blocks HIV Entry and Infection
|
|
December 2009 |
Isolation, chemical investigation and antiviral activity of polysaccharides from Gracilaria corticata (Gracilariaceae, Rhodophyta)
|
|
December 2002 |
Calcium Spirulan, an Inhibitor of Enveloped Virus Replication, from a Blue-Green Alga Spirulina platensis
|
|
January 1996 |
Effects of Structural Modification of Calcium Spirulan, a Sulfated Polysaccharide from Spirulina Platensis, on Antiviral Activity.
|
|
January 2001 |
Anti-herpes Simplex Virus Target of an Acidic Polysaccharide, Nostoflan, from the Edible Blue-Green Alga Nostoc flagelliforme
|
|
January 2007 |
Pressurized Liquid Extraction as an Alternative Process To Obtain Antiviral Agents from the Edible Microalga Chlorella vulgaris
|
|
August 2010 |
Antiviral compounds obtained from microalgae commonly used as carotenoid sources
|
|
May 2011 |
A Natural Sulfated Polysaccharide, Calcium Spirulan, Isolated from Spirulina platensis: In Vitro and ex Vivo Evaluation of Anti-Herpes Simplex Virus and Anti-Human Immunodeficiency Virus Activities
|
|
October 1996 |
Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome (AIDS) drug candidate, targeting CD4 in lymphocytes
|
|
August 2004 |
The potential molecular targets of marine sulfated polymannuroguluronate interfering with HIV-1 entryInteraction between SPMG and HIV-1 rgp120 and CD4 molecule
|
|
July 2003 |
Antiviral activity against enterovirus 71 of sulfated rhamnan isolated from the green alga Monostroma latissimum
|
|
November 2018 |
A sulfated glucuronorhamnan from the green seaweed Monostroma nitidum: Characteristics of its structure and antiviral activity
|
|
January 2020 |
Sulfated polymannuroguluronate, a novel anti-AIDS drug candidate, inhibits HIV-1 Tat-induced angiogenesis in Kaposi's sarcoma cells
|
|
November 2007 |
HIV: Cell Binding and Entry
|
|
April 2012 |
A comprehensive pathway map of epidermal growth factor receptor signaling
|
|
January 2005 |
The Epidermal Growth Factor Receptor (EGFR) Promotes Uptake of Influenza A Viruses (IAV) into Host Cells
|
|
September 2010 |
Proteins and Carbohydrates from Red Seaweeds: Evidence for Beneficial Effects on Gut Function and Microbiota
|
|
August 2015 |
Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga
|
|
November 2008 |
Interference in dengue virus adsorption and uncoating by carrageenans
|
|
July 2007 |
The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell
|
|
June 2005 |
Anti-Chikungunya Viral Activities of Aplysiatoxin-Related Compounds from the Marine Cyanobacterium Trichodesmium erythraeum
|
|
January 2014 |
Dolastatin 3 and Two Novel Cyclic Peptides from a Palauan Collection of Lyngbya m ajuscula
|
|
February 2000 |
Inhibition of HIV-1 Reverse Transcriptase and Protease by Phlorotannins from the Brown Alga Ecklonia cava
|
|
January 2004 |
Inhibitory activity on HIV-1 reverse transcriptase and integrase of a carmalol derivative from a brown Alga,Ishige okamurae
|
|
January 2006 |
Overview on the antiviral activities and mechanisms of marine polysaccharides from seaweeds
|
|
December 2017 |
Antiviral Potential of Algae Polysaccharides Isolated from Marine Sources: A Review
|
|
January 2015 |
Purification and characterization of an avian myeloblastosis and human immunodeficiency virus reverse transcriptase inhibitor, sulfated polysaccharides extracted from sea algae.
|
|
October 1987 |
Sulfoquinovosyldiacylglycerol, KM043, a New Potent Inhibitor of Eukaryotic DNA Polymerases and HIV-Reverse Transcriptase Type 1 from a Marine Red Alga, Gigartina tenella.
|
|
January 1998 |
Inhibition of Reverse Transcriptase Activity by Extracts of Cultured Blue-Green Algae (Cyanophyta)
|
|
April 1993 |
Use of microalgae Chlamydomonas reinhardtii for production of double-stranded RNA against shrimp virus
|
|
May 2016 |
Advances in algal drug research with emphasis on enzyme inhibitors
|
|
December 2014 |
Evaluation of HIV-1 inhibition by stereoisomers and analogues of the sesquiterpenoid hydroquinone peyssonol A
|
|
April 2013 |
The hepatitis B virus
|
|
October 1985 |
The Potential of Algal Biotechnology to Produce Antiviral Compounds and Biopharmaceuticals
|
|
September 2020 |
Dieckol, a SARS-CoV 3CLpro inhibitor, isolated from the edible brown algae Ecklonia cava
|
|
July 2013 |
Cyclic Depsipeptides, Ichthyopeptins A and B, from Microcystis ichthyoblabe
|
|
July 2007 |
Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds
|
|
October 2005 |
Sterols in red algae (Rhodophyceae)1
|
|
April 1968 |
SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity
|
|
October 2016 |
Lead- and drug-like compounds: the rule-of-five revolution
|
|
December 2004 |
ADMET—turning chemicals into drugs
|
|
August 2001 |
Results of a Large Scale Screen of Microalgae for the Production of Protease Inhibitors
|
|
February 1988 |
Mechanisms of Viral Membrane Fusion and Its Inhibition
|
|
June 2001 |
Influenza Virus Neuraminidase Inhibitory Activity of Phlorotannins from the Edible Brown Alga Ecklonia cava
|
|
June 2011 |
Cyanovirin-N potently inhibits human immunodeficiency virus type 1 infection in cellular and cervical explant models
|
|
January 2009 |
Microvirin, a Novel α(1,2)-Mannose-specific Lectin Isolated from Microcystis aeruginosa, Has Anti-HIV-1 Activity Comparable with That of Cyanovirin-N but a Much Higher Safety Profile
|
|
August 2010 |
Influenza Neuraminidase: A Neglected Protein and Its Potential for a Better Influenza Vaccine
|
|
July 2020 |
Roles of neuraminidase in the initial stage of influenza virus infection
|
|
April 2006 |
Myristoylation as a target for inhibiting HIV assembly: Unsaturated fatty acids block viral budding
|
|
September 2002 |
Antimycobacterial Activity of the Red Alga Polysiphonia virgata .
|
|
January 2008 |
Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase
|
|
November 1987 |
Inhibition of HIV-1 Replication by an Aqueous Extract of Spirulina platensis (Arthrospira platensis)
|
|
January 1998 |
Micro RNA Expression after Ingestion of Fucoidan; A Clinical Study
|
|
February 2020 |
Sulfated glycans induce rapid hematopoietic progenitor cell mobilization: evidence for selectin-dependent and independent mechanisms
|
|
October 2000 |
Fucoidan from sea cucumber Holothuria polii: Structural elucidation and stimulation of hematopoietic activity
|
|
July 2020 |
Therapeutic effects of an orally administered edible seaweed-derived polysaccharide preparation, ascophyllan HS, on a Streptococcus pneumoniae infection mouse model
|
|
July 2020 |
Ascophyllan Purified from Ascophyllum nodosum Induces Th1 and Tc1 Immune Responses by Promoting Dendritic Cell Maturation
|
|
July 2014 |
The potent activity of sulfated polysaccharide, ascophyllan, isolated from Ascophyllum nodosum to induce nitric oxide and cytokine production from mouse macrophage RAW264.7 cells: Comparison between ascophyllan and fucoidan
|
|
November 2011 |
Oral administration of a Spirulina extract enriched for Braun-type lipoproteins protects mice against influenza A (H1N1) virus infection
|
|
February 2015 |
Immolina, a High–Molecular-Weight Polysaccharide Fraction of Spirulina, Enhances Chemokine Expression in Human Monocytic THP-1 Cells
|
|
June 2006 |
Oral administration of Euglena gracilis Z and its carbohydrate storage substance provides survival protection against influenza virus infection in mice
|
|
December 2017 |
Nanoparticles assembled from fucoidan and trimethylchitosan as anthrax vaccine adjuvant: In vitro and in vivo efficacy in comparison to CpG
|
|
May 2020 |
Nitric oxide and virus infection: NO and virus infection
|
|
November 2000 |
MHC Class I Molecules Exacerbate Viral Infection by Disrupting Type I Interferon Signaling
|
|
September 2019 |
Marine Algal Antioxidants as Potential Vectors for Controlling Viral Diseases
|
|
May 2020 |
Oxidative stress influences positive strand RNA virus genome synthesis and capping
|
|
January 2015 |
Challenges at the Time of COVID-19: Opportunities and Innovations in Antivirals from Nature
|
|
May 2020 |
Antiviral and Antioxidant Properties of Echinochrome A
|
|
December 2018 |
Antioxidant Therapy as a Potential Approach to Severe Influenza-Associated Complications
|
|
February 2011 |
Inhibitory effect of diphlorethohydroxycarmalol on melanogenesis and its protective effect against UV-B radiation-induced cell damage
|
|
May 2010 |
Evaluation of diphlorethohydroxycarmalol isolated from Ishige okamurae for radical scavenging activity and its protective effect against H2O2-induced cell damage
|
|
April 2009 |
Antioxidant role of astaxanthin in the green alga Haematococcus pluvialis
|
|
September 1997 |
The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus
|
|
February 2020 |
Remdesivir for the Treatment of Covid-19 — Final Report
|
|
November 2020 |
Man-Specific, GalNAc/T/Tn-Specific and Neu5Ac-Specific Seaweed Lectins as Glycan Probes for the SARS-CoV-2 (COVID-19) Coronavirus
|
|
October 2020 |
The structure-activity relationship of the interactions of SARS-CoV-2 spike glycoproteins with glucuronomannan and sulfated galactofucan from Saccharina japonica
|
|
November 2020 |
COVID-19: consider cytokine storm syndromes and immunosuppression
|
|
March 2020 |